Todd Alfred Carter Voyager Therapeutics, Inc. (VYGR) insider trading activity

Todd Alfred Carter is Chief Scientific Officer of Voyager Therapeutics, Inc.. Currently has a direct ownership of 123,718 shares of VYGR, which is worth approximately $509,718. The most recent transaction as insider was on Feb 21, 2025, when has been sold 46,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 124K

41.19% 3M change

41.19% 12M change

Total Value Held $509,718

Todd Alfred Carter Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 21 2025	BUY Grant, award, or other acquisition	-	46,000 Added 27.1%	123,718 Common Stock
Feb 20 2025	SELL Open market or private sale	$14,079 $4.26 p/Share	3,305 Reduced 4.08%	77,718 Common Stock
Feb 11 2025	SELL Open market or private sale	$24,087 $4.45 p/Share	5,413 Reduced 6.26%	81,023 Common Stock
Jan 14 2025	SELL Open market or private sale	$6,109 $5.13 p/Share	1,191 Reduced 1.36%	86,436 Common Stock
Feb 21 2024	SELL Open market or private sale	$25,136 $7.47 p/Share	3,365 Reduced 3.7%	87,627 Common Stock
Feb 20 2024	SELL Open market or private sale	$4,623 $7.68 p/Share	602 Reduced 0.66%	90,992 Common Stock
Feb 09 2024	BUY Grant, award, or other acquisition	-	38,500 Added 29.59%	91,594 Common Stock
Jan 17 2024	SELL Open market or private sale	$9,089 $7.18 p/Share	1,266 Reduced 2.33%	53,094 Common Stock
Sep 15 2023	SELL Open market or private sale	$85,680 $8.16 p/Share	10,500 Reduced 16.19%	54,360 Common Stock
Sep 15 2023	BUY Exercise of conversion of derivative security	$14,250 $2.85 p/Share	5,000 Added 7.16%	64,860 Common Stock
Jul 06 2023	SELL Open market or private sale	$59,400 $10.8 p/Share	5,500 Reduced 8.41%	59,860 Common Stock
Jun 30 2023	SELL Open market or private sale	$57,050 $11.41 p/Share	5,000 Reduced 7.11%	65,360 Common Stock
Jun 30 2023	BUY Exercise of conversion of derivative security	$14,250 $2.85 p/Share	5,000 Added 6.63%	70,360 Common Stock
Mar 20 2023	SELL Open market or private sale	$17,017 $7.76 p/Share	2,193 Reduced 3.25%	65,360 Common Stock
Feb 17 2023	SELL Open market or private sale	$5,498 $7.45 p/Share	738 Reduced 1.08%	67,553 Common Stock
Feb 17 2023	BUY Grant, award, or other acquisition	-	34,000 Added 33.24%	68,291 Common Stock
Feb 13 2023	SELL Open market or private sale	$6,112 $7.67 p/Share	797 Reduced 2.27%	34,291 Common Stock
Jan 17 2023	SELL Open market or private sale	$11,015 $9.96 p/Share	1,106 Reduced 3.06%	35,088 Common Stock
Jan 06 2023	SELL Open market or private sale	$2,487 $6.41 p/Share	388 Reduced 1.06%	36,194 Common Stock
Dec 31 2022	BUY Grant, award, or other acquisition	$2,005 $5.17 p/Share	388 Added 1.05%	36,582 Common Stock

TAC

Todd Alfred Carter

Chief Scientific Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYGR shares.

Notify only if

Value

Insider Trading

Get notified when an Voyager Therapeutics, Inc. insider buys or sells VYGR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Voyager Therapeutics, Inc.

Track Activities on VYGR

Account